Evaluating the Efficacy of Convalescent Plasma in Symptomatic Outpatients Infected With COVID-19
NCT04438057
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
103
Enrollment
OTHER
Sponsor class
Conditions
COVID-19
Interventions
BIOLOGICAL:
CCP
Sponsor
Metro Infectious Disease Consultants